USD 7.41
(19.71%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -47.50 USD | -141.36% |
2022 | -19.68 USD | -43.96% |
2021 | -13.67 USD | 70.1% |
2020 | -45.72 USD | -6.42% |
2019 | -42.96 USD | -65.49% |
2018 | -25.96 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -3.36 USD | 31.98% |
2024 Q3 | -2.87 USD | 14.58% |
2024 Q1 | -4.94 USD | -46.59% |
2023 Q3 | -9.54 USD | -46.09% |
2023 FY | - USD | -141.36% |
2023 Q1 | -28.42 USD | -551.83% |
2023 Q2 | -6.53 USD | 77.02% |
2023 Q4 | -3.37 USD | 64.68% |
2022 Q2 | -5.06 USD | 3.25% |
2022 Q1 | -5.23 USD | -45.68% |
2022 Q3 | -5.05 USD | 0.2% |
2022 Q4 | -4.36 USD | 13.66% |
2022 FY | - USD | -43.96% |
2021 Q2 | -3.04 USD | 5.59% |
2021 Q4 | -3.59 USD | 10.25% |
2021 Q3 | -4.00 USD | -31.58% |
2021 FY | - USD | 70.1% |
2021 Q1 | -3.22 USD | 22.6% |
2020 FY | - USD | -6.42% |
2020 Q4 | -4.16 USD | 77.42% |
2020 Q3 | -18.42 USD | 53.79% |
2020 Q2 | -39.86 USD | -246.31% |
2020 Q1 | -11.51 USD | -0.44% |
2019 FY | - USD | -65.49% |
2019 Q4 | -11.46 USD | -0.09% |
2019 Q3 | -11.45 USD | -19.77% |
2019 Q2 | -9.56 USD | 7.63% |
2019 Q1 | -10.35 USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Doximity, Inc. | 0.78 USD | 6189.744% |
Evolent Health, Inc. | -1.28 USD | -3610.938% |
MultiPlan Corporation | -0.14 USD | -33828.571% |
Phreesia, Inc. | -2.51 USD | -1792.43% |
Teladoc Health, Inc. | -1.36 USD | -3392.647% |
Veeva Systems Inc. | 3.27 USD | 1552.599% |